ILLUMINA INC (ILU.DE) Stock Price & Overview
FRA:ILU • US4523271090
The current stock price of ILU.DE is 111.26 EUR. Today ILU.DE is down by -0.68%. In the past month the price decreased by -5.34%. In the past year, price increased by 44.01%.
ILU.DE Key Statistics
- Market Cap
- 17.001B
- P/E
- 26.62
- Fwd P/E
- 24.94
- EPS (TTM)
- 4.18
- Dividend Yield
- N/A
ILU.DE Stock Performance
ILU.DE Stock Chart
ILU.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ILU.DE. When comparing the yearly performance of all stocks, ILU.DE is one of the better performing stocks in the market, outperforming 86.41% of all stocks.
ILU.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE. ILU.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
ILU.DE Earnings
On February 5, 2026 ILU.DE reported an EPS of 1.35 and a revenue of 1.16B. The company beat EPS expectations (7.62% surprise) and beat revenue expectations (2.75% surprise).
ILU.DE Forecast & Estimates
26 analysts have analysed ILU.DE and the average price target is 114.81 EUR. This implies a price increase of 3.19% is expected in the next year compared to the current price of 111.26.
For the next year, analysts expect an EPS growth of 6.75% and a revenue growth 5.78% for ILU.DE
ILU.DE Groups
Sector & Classification
ILU.DE Financial Highlights
Over the last trailing twelve months ILU.DE reported a non-GAAP Earnings per Share(EPS) of 4.18. The EPS increased by 97.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.57% | ||
| ROA | 12.79% | ||
| ROE | 31.22% | ||
| Debt/Equity | 0.55 |
ILU.DE Ownership
ILU.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 56S1 | SARTORIUS STEDIM BIOTECH | 33.66 | 17.485B | ||
| SRT3 | SARTORIUS AG-VORZUG | 38.08 | 16.818B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 32.42 | 16.259B | ||
| SRT | SARTORIUS AG | 30.31 | 13.344B | ||
| QIA | QIAGEN N.V. | 17.71 | 8.384B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 12.53 | 2.118B | ||
| EVT | EVOTEC SE | N/A | 1.883B | ||
| GXI | GERRESHEIMER AG | 5.55 | 556.439M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 16.17 | 248.175M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 159M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About ILU.DE
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA US
Employees: 9000
Phone: 18582024500
ILLUMINA INC / ILU.DE FAQ
What does ILLUMINA INC do?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
What is the current price of ILU stock?
The current stock price of ILU.DE is 111.26 EUR. The price decreased by -0.68% in the last trading session.
Does ILLUMINA INC pay dividends?
ILU.DE does not pay a dividend.
How is the ChartMill rating for ILLUMINA INC?
ILU.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is ILLUMINA INC (ILU.DE) stock traded?
ILU.DE stock is listed on the Frankfurt Stock Exchange exchange.